TuHURA Biosciences (HURA) Share-based Compensation (2012 - 2026)

TuHURA Biosciences' Share-based Compensation history runs 15 years deep, the most recent figure standing at $21.4 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 1402.03% year-over-year to $21.4 million in Q1 2026; TTM through Mar 2026 was $21.4 million, a 622.07% increase from a year earlier, with the FY2025 full-year figure at $21.5 million, up 50.35% from the prior year.
• Share-based Compensation advanced to $21.4 million in Q1 2026 per HURA's latest filing, from -$4.1 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $21.4 million in Q1 2026 and bottomed at -$4.1 million in Q4 2025.
• The 5-year median for Share-based Compensation is $642000.0 (2022), against an average of $4.0 million.
• Across the five-year window, Share-based Compensation tumbled 223.05% in 2023 and surged 4300.0% in 2024, its largest moves.
• Year by year, Share-based Compensation stood at $907000.0 in 2022, then sank by 64.17% to $325000.0 in 2023, then jumped by 4300.0% to $14.3 million in 2024, then plunged by 128.62% to -$4.1 million in 2025, then jumped by 622.94% to $21.4 million in 2026.
• Per Business Quant, the three latest HURA Share-based Compensation figures stand at $21.4 million (Q1 2026), -$4.1 million (Q4 2025), and $11.0 million (Q3 2025).